Atossa Therapeutics, Inc. (ATOS)
4.95
+0.23
(+4.87%)
USD |
NASDAQ |
Mar 04, 12:55
Atossa Therapeutics Cash from Financing (Quarterly) : 0.00 for Sept. 30, 2025
Cash from Financing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 1.349M |
| Plus Therapeutics, Inc. | 12.31M |
| Abeona Therapeutics, Inc. | 5.163M |
| Cell Source, Inc. | 0.80M |
| Kiora Pharmaceuticals, Inc. | 0.00 |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -6.005M |
| Cash from Investing (Quarterly) | -0.007M |
| Free Cash Flow | -26.29M |
| Free Cash Flow Per Share (Quarterly) | -0.6981 |
| Free Cash Flow to Equity (Quarterly) | -6.012M |
| Free Cash Flow to Firm (Quarterly) | -6.012M |
| Free Cash Flow Yield | -13.72% |